Form 4: Madrigal Pharmaceuticals Director Richard S. Levy Executes Stock Option and Sells Shares

Director Richard S. Levy exercised stock options and sold shares of Madrigal Pharmaceuticals (MDGL) on November 1, 2024, according to a Form 4 filing with the SEC.

Summary

• Richard S. Levy, a director at Madrigal Pharmaceuticals, executed a stock option to acquire 5,000 shares of common stock at a price of $7.36 on November 1, 2024.
• On the same day, Levy sold 2,800 shares at a weighted average price of $300.0993, 1,100 shares at $301.2173, 800 shares at $302.2488 and 300 shares at $304.291.
• These sales were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on November 30, 2023.
• Following these transactions, Levy directly owns 11,012 shares of Madrigal Pharmaceuticals common stock and holds options for 10,000 shares.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about insider trading activity.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge insider sentiment and potential future stock performance.

Stakeholder Impact

• Shareholders may interpret the insider selling activity as a signal, although the sales were conducted under a pre-arranged trading plan.

Key Dates